Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | PRKDC | P78527 | 3/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18273114 | 0.94 | ALOX5 (0.33) | ALOX5PRKDCTSHR | |
| SCHEMBL19009322 | 0.90 | ALOX5 (0.36) | ALOX5PRKDCGGPS1TSHR | |
| SCHEMBL18273131 | 0.90 | ALOX5 (0.44) | ALOX5PRKDCGGPS1PRMT5WDR77 | |
| SCHEMBL22352550 | 0.88 | PRKDC (0.34) | PRKDC | |
| SCHEMBL17695009 | 0.88 | TSHR (0.32) | ALOX5TSHR | |
| SCHEMBL18273141 | 0.88 | ALOX5 (0.36) | ALOX5PRKDCGGPS1TSHR | |
| SCHEMBL18273119 | 0.87 | ALOX5 (0.41) | ALOX5PRKDCGGPS1PTGES2TSHR | |
| SCHEMBL18269987 | 0.87 | ALOX5 (0.41) | ALOX5PRKDCGGPS1PTGES2TSHR | |
| SCHEMBL18273125 | 0.87 | ALOX5 (0.41) | ALOX5PRKDCGGPS1PTGES2TSHR | |
| SCHEMBL18273227 | 0.87 | ALOX5 (0.41) | ALOX5PRKDCGGPS1PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160351826-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160351826-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ALOX5 1855/4885PRKDC 4440/4885GGPS1 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.